| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |